Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea · Delayed Price · Currency is KRW

89,000

+500 (0.56%)

Aug 7, 2026, 3:30 PM KST

-19.66% (1Y)

Market Cap	589.96B -19.7%
Revenue (ttm)	1.45T +7.1%
Net Income	93.70B +37.7%
EPS	14,102.68 +37.4%
Shares Out	6.63M
PE Ratio	6.31
Forward PE	7.11
Dividend	1,650.49 (1.86%)
Ex-Dividend Date	Jul 30, 2026

Volume	9,154
Open	88,200
Previous Close	88,500
Day's Range	87,300 - 89,700
52-Week Range	74,500 - 121,845
Beta	0.09
Analysts	Strong Buy
Price Target	145,000.00 (+62.92%)
Earnings Date	Oct 27, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1932

Employees 83

Stock Exchange Korea Stock Exchange

Ticker Symbol 000640

Full Company Profile

Financial Performance

In 2025, Dong-A Socio Holdings's revenue was 1.43 trillion, an increase of 7.24% compared to the previous year's 1.33 trillion. Earnings were 90.94 billion, an increase of 56.74%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 000640 stock is "Strong Buy." The 12-month stock price target is ₩145,000, which is an increase of 62.92% from the latest price.

Price Target

₩145,000

(62.92% upside)

Analyst Consensus: Strong Buy

Stock Forecasts